Quantcast

Latest Idenix Pharmaceuticals Inc. Stories

2011-08-08 15:05:00

CAMBRIDGE, Mass., Aug. 8, 2011 /PRNewswire/ -- Lead nucleotide polymerase inhibitor IDX184 advancing clinically - The Company has initiated dosing of IDX184 in combination with pegylated interferon and ribavirin (Peg-IFN/RBV) in a Phase IIb hepatitis C virus (HCV) trial HCV pipeline progressing - The Company has selected IDX719 as lead NS5A candidate, has identified IDX077 and IDX791 as two potential PI preclinical candidates, and is presently focused on generating and selecting...

2011-07-21 15:05:00

CAMBRIDGE, Mass., July 21, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that it will report its financial results for the second quarter of 2011 on Monday, August 8, 2011 after U.S. financial markets close. Idenix management will host a conference call at 4:30 p.m. ET on Monday, August 8, 2011 to discuss the company's financial results for the second quarter of 2011 and provide an update on the company's development programs. To access the call please...

2011-05-26 15:45:00

CAMBRIDGE, Mass., May 26, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the Jefferies 2011 Global Healthcare Conference on June 9, 2011 at 4:00 p.m. ET in New York City. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely...

2011-05-03 15:05:00

CAMBRIDGE, Mass., May 3, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the Bank of America Merrill Lynch 2011 Health Care Conference on May 10, 2011 at 1:40 p.m. PT at the Wynn Encore, Las Vegas. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the...

2011-04-27 15:05:00

CAMBRIDGE, Mass., April 27, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the first quarter of 2011. At March 31, 2011, Idenix's cash and cash equivalents totaled $31.4 million. First Quarter 2011 Financial Results For the first quarter ended March 31, 2011, Idenix reported total revenues of $4.0...

2011-04-08 07:45:00

CAMBRIDGE, Mass., April 8, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix. The offering is expected to close on April 13, 2011, subject to customary...

2011-04-07 15:02:00

CAMBRIDGE, Mass., April 7, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has commenced an underwritten registered public offering of shares of its common stock. All of these shares are being sold by Idenix. J.P. Morgan Securities LLC is acting as sole book-running manager and underwriter for the offering. Idenix intends to...

2011-03-07 15:29:00

CAMBRIDGE, Mass., March 7, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that two abstracts have been accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL, March 30- April 3, 2011 in Berlin, Germany). Full abstracts can now be viewed at the EASL website at www.easl.eu. The...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related